Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chara Kani
Observed names:
C Kani,
C. Kani,
Kani, Chara
Institutions:
National and Kapodistrian University of Athens,
Ministry of Health
Observed institutions:
University of Peloponnese,
National and Kapodistrian University of Athens,
Social Insurance Institute,
National Public Health Organization,
Ministry of Health
ORCID:
0000-0002-5617-5948
Observed ORCID:
0000-0002-5617-5948
OpenAlex ID:
A5070729688
The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database
2016
·
Stavros Liatis
, George E. Dafoulas
, et al.
·
Diabetes Research and Clinical Practice
·
83
Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
2019
·
Aristeidis Skandamis
, Chara Kani
, et al.
·
Journal of Drug Assessment
·
30
PDF
Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
2017
·
Petros P Sfikakis
, Vasiliki-Kalliopi Bournia
, et al.
·
PubMed
·
29
Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease
2016
·
Kyriakos Souliotis
, Chara Kani
, et al.
·
PLoS ONE
·
19
PDF
Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
2019
·
Kyriakos Souliotis
, Christina Golna
, et al.
·
PLoS ONE
·
11
PDF
End-of-Life Health-Care Cost of Patients With Lung Cancer: A Retrospective Study
2019
·
Kyriakos Souliotis
, Chara Kani
, et al.
·
Health Services Research and Managerial Epidemiology
·
11
PDF
Monitoring of subcutaneous dalteparin in patients with renal insufficiency under intensive care: an observational study
2006
·
Chara Kani
, Sophia L. Markantonis
, et al.
·
Journal of Critical Care
·
10
Systematic Review and Meta-Analysis of the Efficacy and Safety of Metformin and GLP-1 Analogues in Children and Adolescents with Diabetes Mellitus Type 2
2022
·
Elisabeth Carydias
, Andoneta Tasho
, et al.
·
Children
·
9
PDF
Current Environment for Introducing Health Technology Assessment in Greece
2017
·
Chara Kani
, Vasilios Kourafalos
, et al.
·
International Journal of Technology Assessment in Health Care
·
8
Greek National E-Prescribing System: Preliminary Results of a Tool for Rationalizing Pharmaceutical Use and Cost
2016
·
Nikolaos Polyzos
, Catherine Kastanioti
, et al.
·
Global Journal of Health Science
·
7
PDF
Health technology assessment of medicinal products in Greece: a 5-year (2018–2023) review of timelines and productivity
2024
·
Athanasios Chantzaras
, Athanasios Margetis
, et al.
·
International Journal of Technology Assessment in Health Care
·
5
PDF
Drug Consumption During the 2004 Olympics: The Special Olympic Pharmacy
2005
·
Maria Skouroliakou
, Chara Kani
, et al.
·
Pharmacy World & Science
·
5
The Impact of Economic Crisis on Drug Consumption and Pharmaceutical Expenditure in Greece
2016
·
A Giannakou
, C Kani
, et al.
·
Value in Health
·
3
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?
2011
·
C. Kani
, P. Litsa
, et al.
·
Value in Health
·
3
Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece
2019
·
Kyriakos Souliotis
, Christina Golna
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
2
Drug Utilization Patterns and Costs of Erythropoiesis-Stimulating Agents in an Outpatient Setting in Greece
2016
·
Apostolos Papachristos
, Chara Kani
, et al.
·
The Consultant Pharmacist
·
2
HTA22 Access to Orphan Pediatric and Adolescent Medicinal Products in Greece Over 4 Years (2018-2021)
2023
·
A. Margetis
, C. Kani
, et al.
·
Value in Health
·
1
PDF
HTA173 Time to Access Orphan Medicines in Greece
2023
·
A. Chantzaras
, A. Margetis
, et al.
·
Value in Health
·
1
PDF
HTA235 Time to Health Technology Assessment of New Medicinal Products in Greece
2022
·
A Chantzaras
, A Margetis
, et al.
·
Value in Health
·
1
HTA182 Time to Access Pediatric/Adolescent vs Adult Medicinal Products in Greece
2022
·
A Margetis
, C Kani
, et al.
·
Value in Health
·
1
PDF
POSA273 Systematic Review, Meta-Analysis of Per OS Administered Drugs in Cystic Fibrosis
2022
·
A Koutsovasili
, K Gogas
, et al.
·
Value in Health
·
1
PDF
Systematic Review and Network Meta-Analysis of Approved Medicines for the Treatment of Idiopathic Pulmonary Fibrosis
2018
·
A Skandamis
, C Kani
, et al.
·
Value in Health
·
1
PDF
Health Expenditure By Disease Age And Gender In Greece
2016
·
O Siskou
, M Schneider
, et al.
·
Value in Health
·
1
PDF
Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece
2016
·
Kyriakos Souliotis
, Christina Golna
, et al.
·
Journal of Medical Economics
·
1
PDF
SAT0361 Large, Nation-Wide Data Analysis-Derived Estimated Prevalence of Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Systemic Sclerosis (SSC) in Caucasians: Insights from the Identification of Patients with Prescribed Pharmacological Treatment Among 7.742.629 Greek Citizens
2015
·
P. Sfikakis
, G. Dafoulas
, et al.
·
Annals of the Rheumatic Diseases
·
1
Show more works
View as search
Works count:
43
Citation count:
246
H-index:
8
I10-index:
7
Year
Topic
Type
